Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_assertion type Assertion NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_head.
- NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_provenance.
- NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_assertion evidence source_evidence_literature NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_provenance.
- NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_assertion SIO_000772 23868767 NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_provenance.
- NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_assertion wasDerivedFrom befree-2016 NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_provenance.
- NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_assertion wasGeneratedBy ECO_0000203 NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_provenance.